학술논문
475O - mFOLFOXIRI + panitumumab versus FOLFOXIRI as first-line treatment in patients with RAS wild-type metastatic colorectal cancer m(CRC): A randomized phase II VOLFI trial of the AIO (AIO-KRK0109)
Document Type
Abstract
Author
Source
In Annals of Oncology September 2017 28 Supplement 5:v159-v159
Subject
Language
ISSN
0923-7534